Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Warns Supplement Own Labeler About Reliance On Manufacturer For Compliance

Sep 01 2020

• By Malcolm Spicer

Stamp with word warning inside,vector illustration

Related Content

Own-Labeler Lesson, Ingredient-Testing Lapse Noted Again In FDA Warnings

Sep 04 2019

ForMor Challenges FDA On Own-Label Supplement GMP Stance

May 06 2013

Additional Topics

United States US States Regulation FDA Dietary Supplements Advertising, Marketing & Sales Commercial Companies Compliance Enforcement Ingredients Manufacturing Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window